Desensitization to Antibiotic Allergies (BCIDP + ACPE Credit)

Desensitization to Antibiotic Allergies (BCIDP + ACPE Credit) is organized by Society of Infectious Diseases Pharmacists (SIDP) and will be held from Jun 27, 2019 - Jun 27, 2022.

Accreditation:
Pharmacists
This activity is jointly provided by ProCE, Inc. and the Society of Infectious Diseases Pharmacists. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers.

Course Description:
Beta-lactam, sulfa, and fluoroquinolone allergies are the most commonly reported antibiotic allergies. There are conflicting practice habits about the safety of using antibiotics within the same class as the primary allergen. This results in the avoidance of all first line medications for patients labeled as penicillin, sulfa, or fluoroquinolone allergic. This webinar will use five clinical scenarios to explore treatment options for patients with antibiotic allergies. The cases will focus on use of sulfonamide nonantibiotics in patients with sulfa antibiotic allergies, use of ceftriaxone and cefazolin in patients with penicillin allergies, oral amoxicillin/penicillin challenge for patients with penicillin allergies, and fluoroquinolone cross-reactivity.

Learning Objectives:
The target audience for this activity includes pharmacists. At the completion of this activity, the participant will be able to:
• Discuss physiology of hypersensitivity reactions.
• Identify the mechanisms of cross-reactivity between and among sulfa containing medications,   beta-lactams, and fluoroquinolones.
• Interpret the available clinical evidence measuring risk of hypersensitivity.
• Explain how to create antimicrobial regimens for patients with antimicrobial allergies.

 Additional details will be posted as soon as they are available.